1-9 of 9
Jaroslav Cermak, M.D., Ph.D.
Close
Sort by
Journal Articles

Frequency and Prognostic Impact of Complex Chromosomal Aberrations in Patients with Primary Myelodysplastic Syndromes and Del(5q).

Zuzana Zemanova, Ass.Prof., Ph.D., Kyra Michalova, Prof., PhD., Jana Brezinova, Libuse Lizcova, Silvia Izakova, Dagmar Bystricka, PhD, Iveta Sarova, Adela Berkova, MD, Magda Siskova, MD, Radana Neuwirtova, MD, PhD, Olga Cerna, MD, Jaroslav Cermak, M.D., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 1623.
https://doi.org/10.1182/blood.V114.22.1623.1623
Published: 2009
Journal Articles

A Distinct Expression of Various Gene Subsets in CD34+ Cells Obtained From Patients with Early and Advanced Myelodysplastic Syndrome.

Monika Belickova, Jaroslav Cermak, M.D., Ph.D., Alzbeta Vasikova, Eva Budinska
Journal: Blood
Blood (2009) 114 (22): 3795.
https://doi.org/10.1182/blood.V114.22.3795.3795
Published: 2009
Journal Articles

New Mutation in ALAS2 as the Cause of X-Linked Sideroblastic Anemia Responsive to Pyridoxine: Comparison of ALAS2-Defective and DMT1-Defective BFU-E Growth.

Jana Kucerova, MSc, Monika Horvathova, MSc, PhD, Petra Belohlavkova, MD, Jaroslav Cermak, M.D., Ph.D., Vladimir Divoky, PhD
Journal: Blood
Blood (2009) 114 (22): 4051.
https://doi.org/10.1182/blood.V114.22.4051.4051
Published: 2009
Journal Articles

Modification of WPSS for the Time of Diagnosis Retains Its Prognostic Impact and Confirms Transfusion Dependency as An Important Parameter Affecting Survival in Early MDS Patients with Isolated Erythroid Dysplasia.

Jaroslav Cermak, M.D., Ph.D., Dana Mikulenkova, M.D., Petra Kacirkova, M.D., Kyra Michalova, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 1654.
https://doi.org/10.1182/blood.V112.11.1654.1654
Published: 2008
Journal Articles

Molecular Cytogenetic Studies of Complex Karyotypes in Myelodysplastic Syndromes (MDS): Conventional Cytogenetics, FISH and Multiplex FISH (mFISH/mBAND)

Zuzana Zemanova, Ph.D., Kyra Michalova, Ph.D., Jana Brezinova, Ph.D., Libuse Lizcova, Silvia Izakova, Magda Siskova, MD, Olga Cerna, MD, Jaroslav Cermak, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 5075.
https://doi.org/10.1182/blood.V112.11.5075.5075
Published: 2008
Journal Articles

Can Gene Methylation, Telomere Length and Activity of Telomerase Help with Individual Risk and Treatment Strategy of MDS Patients?

Hana Cechova, Sona Vcelikova, Hana Lastuvkova, Martina Skalova, Zuzana Zemanova, Kyra Michalova, Jaroslav Cermak, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 5087.
https://doi.org/10.1182/blood.V112.11.5087.5087
Published: 2008
Journal Articles

Gene Expression Profiles of CD34+ Cells in Myelodysplastic Syndrome

Monika Belickova, Alzbeta Vasikova, Eva Budinska, Jaroslav Cermak, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 5078.
https://doi.org/10.1182/blood.V112.11.5078.5078
Published: 2008
Journal Articles

Telomere Length Reduction in Patients with Early Myelodysplastic Syndrome (MDS) Is Connected with Presence of Karyotype Abnormalities and with Shortened Survival and May Serve as an Additional Prognostic Factor.

Zuzana Sieglova, Ph.D., Jaroslav Cermak, M.D., Ph.D., Sona Zilovcova, Ph.D., Hana Zizkova, Ph.D., Kyra Michalova, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2377.
https://doi.org/10.1182/blood.V104.11.2377.2377
Published: 2004
Journal Articles

Achievement of Low or Intermediate-1 Risk Score after Combination Chemotherapy before Stem Cell Transplantation (SCT) May Be Associated with Prolonged Disease-Free Survival (DFS) in Patients with Advanced Myelodysplastic Syndrome (MDS).

Jaroslav Cermak, M.D., Ph.D., Antonin Vitek, M.D., Marcela Lukasova, M.D., Kyra Michalova, Ph.D., Petr Cetkovsky, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 1443.
https://doi.org/10.1182/blood.V104.11.1443.1443
Published: 2004